A Phase 2 Study to Evaluate the Efficacy and Safety of VIR-2482 for the Prevention of Illness Due to Influenza A
Trial details
- Registry ID
- NCT05567783
- Phase
- Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| A Phase 2 Study to Evaluate the Efficacy and Safety of VIR-2482 for the Prevention of Illness Due to Influenza ANCT05567783 | VIR | Phase 2 | Terminated | 2023-05-05Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |